Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

16.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CTx001 for Geographic Atrophy: A Gene Therapy Expressing Soluble, Truncated Complement Receptor 1 (Mini-CR1).

Ophthalmology science·2025
Same author

In utero therapy for spinal muscular atrophy: closer to clinical translation.

Brain : a journal of neurology·2025
Same author

Gene therapy for spinal muscular atrophy: perspectives on the possibility of optimizing SMN1 delivery to correct all neurological and systemic perturbations.

Neural regeneration research·2024
Same author

Correction: Andrew C. G. Porter (1955-2023).

Gene therapy·2024
Same author

Andrew C. G. Porter (1955-2023).

Gene therapy·2024
Same author

The British Society for Gene and Cell Therapy at 20 (2003-2023).

Human gene therapy·2023

Related Experiment Video

Updated: Feb 23, 2026

Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification
04:43

Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification

Published on: October 11, 2024

2.6K

Nonintegrating Gene Therapy Vectors.

Takis Athanasopoulos1, Mustafa M Munye1, Rafael J Yáñez-Muñoz2

  • 1Cell and Gene Therapy Discovery Research, Platform Technology and Sciences, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK.

Hematology/Oncology Clinics of North America
|September 13, 2017
PubMed
Summary

Non-integrating gene delivery vectors avoid genome mutation risks but can dilute in dividing cells. This review covers viral and nonviral options for cell and gene therapy, especially for blood disorders.

Keywords:
Adeno-associated virus vectorsAdenovirus vectorsGene therapyGenome editingIntegration-deficient lentiviral vectors (IDLVs)NonintegratingPlasmidPoxvirus vector

More Related Videos

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

10.2K
Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

2.9K

Related Experiment Videos

Last Updated: Feb 23, 2026

Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification
04:43

Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification

Published on: October 11, 2024

2.6K
Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

10.2K
Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

2.9K

Area of Science:

  • Cell and Gene Therapy
  • Molecular Biology
  • Virology

Background:

  • Gene delivery vectors offer therapeutic potential but raise concerns regarding host cell genome integration.
  • Integration can lead to insertional mutagenesis and position effect variegation, impacting safety and efficacy.
  • Non-integrating vectors circumvent these risks, presenting an alternative for gene transfer applications.

Observation:

  • Non-integrating vectors, including viral (adenoviral, adeno-associated viral, integration-deficient retro-lentiviral, poxviral) and nonviral (plasmid vectors, artificial chromosomes) types, are crucial in preclinical and clinical research.
  • These vectors avoid direct insertion into the host genome, mitigating risks associated with genetic modification.
  • However, without engineered replication and segregation, they face dilution in proliferating cells and are susceptible to epigenetic effects.

Findings:

  • This article reviews key non-integrating gene delivery vectors.
  • It highlights their advantages, such as avoiding insertional mutagenesis and position effect variegation.
  • The review emphasizes their application in hematologic diseases.

Implications:

  • Non-integrating vectors provide a safer platform for gene therapy, particularly for conditions requiring transient gene expression.
  • Their use in hematologic diseases shows promise for treating blood disorders without permanent genetic alteration.
  • Further research into optimizing non-integrating vector stability and delivery is essential for advancing cell and gene therapy.